Capabilities and research platforms

We have expertise in structure-based drug design, fragment-based drug discovery and structure-activity guided medicinal chemistry. Most of our research projects also involve considerable synthetic and organic chemistry.

In addition to drug discovery, our capabilities include optimising existing drugs through the study, identification and synthesis of metabolic products and related compounds, and developing chemical probes to study the molecular basis of disease, identify potential new drug targets and improve disease diagnosis.

Research platforms

Medicinal Chemistry theme hosts two research platforms: the Australian Translational Medicinal Chemistry Facility (ATMCF) and the Monash Fragment Platform (MFP).

Find out more